ID   RERE_MOUSE              Reviewed;        1558 AA.
AC   Q80TZ9; A2A7T4;
DT   10-JAN-2006, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 3.
DT   07-APR-2021, entry version 134.
DE   RecName: Full=Arginine-glutamic acid dipeptide repeats protein;
DE   AltName: Full=Atrophin-2;
GN   Name=Rere; Synonyms=Atr2, Kiaa0458;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 673-1558.
RC   TISSUE=Brain;
RX   PubMed=12693553; DOI=10.1093/dnares/10.1.35;
RA   Okazaki N., Kikuno R., Ohara R., Inamoto S., Aizawa H., Yuasa S.,
RA   Nakajima D., Nagase T., Ohara O., Koga H.;
RT   "Prediction of the coding sequences of mouse homologues of KIAA gene: II.
RT   The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs
RT   identified by screening of terminal sequences of cDNA clones randomly
RT   sampled from size-fractionated libraries.";
RL   DNA Res. 10:35-48(2003).
RN   [3]
RP   FUNCTION, INTERACTION WITH ATN1 AND HDAC1, DEVELOPMENTAL STAGE, AND
RP   DISRUPTION PHENOTYPE.
RX   PubMed=14645126; DOI=10.1242/dev.00908;
RA   Zoltewicz J.S., Stewart N.J., Leung R., Peterson A.S.;
RT   "Atrophin 2 recruits histone deacetylase and is required for the function
RT   of multiple signaling centers during mouse embryogenesis.";
RL   Development 131:3-14(2004).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-675 AND SER-679, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-53; SER-56; SER-142; THR-593;
RP   SER-594; SER-600; SER-675; SER-679; SER-1098; SER-1105 AND SER-1107, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Lung, Spleen, and
RC   Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1150, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
CC   -!- FUNCTION: Plays a role as a transcriptional repressor during
CC       development. May play a role in the control of cell survival.
CC       {ECO:0000269|PubMed:14645126}.
CC   -!- SUBUNIT: Interacts with HDAC1 and ATN1. Interaction with ATN1 is
CC       improved when the poly-Gln region of ATN1 is extended. Interacts with
CC       FAT1 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus, PML body {ECO:0000250}. Note=Localized
CC       in nuclear bodies of variables size. Colocalized with PML and BAX in
CC       nuclear PODs (By similarity). {ECO:0000250}.
CC   -!- DEVELOPMENTAL STAGE: At 8.25 dpc expression is strongly elevated in the
CC       anterior midline. At 8.5 dpc expression is elevated throughout the
CC       anteroposterior extent of the notochord and is down-regulated in the
CC       heart. At 8.75 dpc expression is increased in the ventral brain. At 9.5
CC       dpc strong expression appears besides the notochord including the
CC       apical ectodermal ridge (AER), the isthmus and the ventral
CC       diencephalon. At 10.5 dpc expression increases in the notochord, the
CC       AER and spinal and brain neurons. {ECO:0000269|PubMed:14645126}.
CC   -!- DOMAIN: The interaction with ATN1 is mediated by the coiled domain.
CC       {ECO:0000250}.
CC   -!- DISRUPTION PHENOTYPE: Mice embryos exhibit a variety of patterning
CC       defects that first appear at 8.0 dpc. Defects include a specific
CC       failure in ventralization of the anterior neural plate, loss of heart
CC       looping and irregular partitioning of somites. In mutant embryos, Shh
CC       expression fails to initiate along the anterior midline at 8.0 dpc, and
CC       Fgf8 is delocalized from the anterior neural ridge at 8.5 dpc.
CC       {ECO:0000269|PubMed:14645126}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL606982; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL606988; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL691453; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CU210933; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CU210934; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK122287; BAC65569.1; -; Transcribed_RNA.
DR   CCDS; CCDS38979.1; -.
DR   RefSeq; NP_001078961.1; NM_001085492.1.
DR   SMR; Q80TZ9; -.
DR   BioGRID; 213002; 2.
DR   IntAct; Q80TZ9; 3.
DR   STRING; 10090.ENSMUSP00000101307; -.
DR   iPTMnet; Q80TZ9; -.
DR   PhosphoSitePlus; Q80TZ9; -.
DR   EPD; Q80TZ9; -.
DR   jPOST; Q80TZ9; -.
DR   MaxQB; Q80TZ9; -.
DR   PaxDb; Q80TZ9; -.
DR   PeptideAtlas; Q80TZ9; -.
DR   PRIDE; Q80TZ9; -.
DR   ProteomicsDB; 255287; -.
DR   Antibodypedia; 13215; 160 antibodies.
DR   DNASU; 68703; -.
DR   Ensembl; ENSMUST00000105682; ENSMUSP00000101307; ENSMUSG00000039852.
DR   GeneID; 68703; -.
DR   KEGG; mmu:68703; -.
DR   UCSC; uc008vxr.1; mouse.
DR   CTD; 473; -.
DR   MGI; MGI:2683486; Rere.
DR   eggNOG; KOG2133; Eukaryota.
DR   GeneTree; ENSGT00940000153615; -.
DR   HOGENOM; CLU_005292_1_0_1; -.
DR   InParanoid; Q80TZ9; -.
DR   OrthoDB; 136778at2759; -.
DR   TreeFam; TF328554; -.
DR   BioGRID-ORCS; 68703; 5 hits in 54 CRISPR screens.
DR   ChiTaRS; Rere; mouse.
DR   PRO; PR:Q80TZ9; -.
DR   Proteomes; UP000000589; Chromosome 4.
DR   RNAct; Q80TZ9; protein.
DR   Bgee; ENSMUSG00000039852; Expressed in bone marrow and 323 other tissues.
DR   ExpressionAtlas; Q80TZ9; baseline and differential.
DR   Genevisible; Q80TZ9; MM.
DR   GO; GO:0000118; C:histone deacetylase complex; IPI:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0016605; C:PML body; IEA:UniProtKB-SubCell.
DR   GO; GO:0003682; F:chromatin binding; IEA:InterPro.
DR   GO; GO:0001085; F:RNA polymerase II transcription factor binding; IBA:GO_Central.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:MGI.
DR   GO; GO:0003714; F:transcription corepressor activity; IMP:MGI.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0048755; P:branching morphogenesis of a nerve; IMP:MGI.
DR   GO; GO:0021930; P:cerebellar granule cell precursor proliferation; IMP:MGI.
DR   GO; GO:0021691; P:cerebellar Purkinje cell layer maturation; IMP:MGI.
DR   GO; GO:0021549; P:cerebellum development; IMP:MGI.
DR   GO; GO:0006338; P:chromatin remodeling; IPI:MGI.
DR   GO; GO:0048813; P:dendrite morphogenesis; IMP:MGI.
DR   GO; GO:0021942; P:radial glia guided migration of Purkinje cell; IMP:MGI.
DR   CDD; cd00202; ZnF_GATA; 1.
DR   InterPro; IPR002951; Atrophin-like.
DR   InterPro; IPR001025; BAH_dom.
DR   InterPro; IPR000949; ELM2_dom.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR001005; SANT/Myb.
DR   InterPro; IPR017884; SANT_dom.
DR   InterPro; IPR000679; Znf_GATA.
DR   Pfam; PF03154; Atrophin-1; 1.
DR   Pfam; PF01426; BAH; 1.
DR   Pfam; PF01448; ELM2; 1.
DR   Pfam; PF00320; GATA; 1.
DR   SMART; SM00439; BAH; 1.
DR   SMART; SM01189; ELM2; 1.
DR   SMART; SM00717; SANT; 1.
DR   SMART; SM00401; ZnF_GATA; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS51038; BAH; 1.
DR   PROSITE; PS51156; ELM2; 1.
DR   PROSITE; PS51293; SANT; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Coiled coil; Developmental protein; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Repressor;
KW   Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..1558
FT                   /note="Arginine-glutamic acid dipeptide repeats protein"
FT                   /id="PRO_0000083505"
FT   DOMAIN          103..283
FT                   /note="BAH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00370"
FT   DOMAIN          284..387
FT                   /note="ELM2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00512"
FT   DOMAIN          391..443
FT                   /note="SANT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00624"
FT   ZN_FING         507..532
FT                   /note="GATA-type"
FT   COILED          1148..1203
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        738..1110
FT                   /note="Pro-rich"
FT   COMPBIAS        1171..1196
FT                   /note="Arg/Glu-rich (mixed charge)"
FT   COMPBIAS        1292..1314
FT                   /note="Arg/Glu-rich (mixed charge)"
FT   COMPBIAS        1417..1437
FT                   /note="His-rich"
FT   COMPBIAS        1443..1502
FT                   /note="Pro-rich"
FT   MOD_RES         53
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         56
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         120
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9P2R6"
FT   MOD_RES         142
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         304
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9P2R6"
FT   MOD_RES         593
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         594
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         600
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         613
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9P2R6"
FT   MOD_RES         642
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9P2R6"
FT   MOD_RES         656
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9P2R6"
FT   MOD_RES         675
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         679
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17242355,
FT                   ECO:0007744|PubMed:21183079"
FT   MOD_RES         1098
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1105
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1107
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         1111
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9P2R6"
FT   MOD_RES         1150
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:23806337"
FT   MOD_RES         1251
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9P2R6"
FT   MOD_RES         1258
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9P2R6"
FT   CROSSLNK        560
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9P2R6"
FT   CROSSLNK        637
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9P2R6"
FT   CONFLICT        840
FT                   /note="S -> G (in Ref. 2; BAC65569)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1236..1239
FT                   /note="Missing (in Ref. 2; BAC65569)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1558 AA;  171755 MW;  723A76184971CAA3 CRC64;
     MTADKDKDKD KEKDRDRDRD RERDKRDKAR ESENARPRRS CTLEGGAKNY AESDHSEDED
     NDNNSATTEE SNKKSRKKPP KKKSRYERTD TGEITSYITE DDVVYRPGDC VYIESRRPNT
     PYFICSIQDF KLVHSSQACC RSPAPAFCDP PACSLPVAPQ PPQHLSEAGR GPGGSKRDHL
     LMNVKWYYRQ SEVPDSVYQH LVQDRHNEND SGRELVITDP VIKNRELFIS DYVDTYHAAA
     LRGKCNISHF SDIFAAREFK ARVDSFFYIL GYNPETRRLN STQGEIRVGP SHQAKLPDLQ
     PFPSPDGDTV TQHEELVWMP GVSDCDLLMY LRAARSMAAF AGMCDGGSTE DGCVAASRDD
     TTLNALNTLH ESSYDAGKAL QRLVKKPVPK LIEKCWTEDE VKRFVKGLRQ YGKNFFRIRK
     ELLPSKETGE LITFYYYWKK TPEAASSRAH RRHRRQAVFR RIKTRTASTP VNTPSRPPSS
     EFLDLSSASE DDFDSEDSEQ ELKGYACRHC FTTTSKDWHH GGRENILLCT DCRIHFKKYG
     ELPPIEKPVD PPPFMFKPVK EEDDGLSGKH SMRTRRSRGS MSTLRSGRKK QPTSPDGRAS
     PINEDIRSSG RNSPSAASTS SNDSKAETVK KSAKKVKEEA ASPLKSTKRQ REKVASDTED
     TDRITSKKTK TQEISRPNSP SEGEGESSDS RSVNDEGSSD PKDIDQDNRS TSPSIPSPQD
     NESDSDSSAQ QQMLQAQPPA LQAPSGAASA PSTAPPGTPQ LPTQGPTPSA TAVPPQGSPA
     TSQPPNQTQS TVAPAAHTHI QQAPTLHPPR LPSPHPPLQP MTAPPSQSSA QPHPQPSLHS
     QGPPGPHSLQ TGPLLQHPGP PQPFGLPSQP SQGQGPLGPS PAAAHPHSTI QLPASQSALQ
     PQQPPREQPL PPAPLAMPHI KPPPTTPIPQ LPAPQAHKHP PHLSGPSPFS LNANLPPPPA
     LKPLSSLSTH HPPSAHPPPL QLMPQSQPLP SSPAQPPGLT QSQSLPPPAA SHPTTGLHQV
     PSQSPFPQHP FVPGGPPPIT PPSCPPTSTP PAGPSSSSQP PCSAAVSSGG SVPGAPSCPL
     PAVQIKEEAL DEAEEPESPP PPPRSPSPEP TVVDTPSHAS QSARFYKHLD RGYNSCARTD
     LYFMPLAGSK LAKKREEAIE KAKREAEQKA REEREREKEK EKERERERER EREAERAAKA
     SSSAHEGRLS DPQLSGPGHM RPSFEPPPTT IAAVPPYIGP DTPALRTLSE YARPHVMSPT
     NRNHPFYMPL NPTDPLLAYH MPGLYNVDPT IRERELRERE IREREIRERE LRERMKPGFE
     VKPPELDPLH PATNPMEHFA RHSALTIPPA AGPHPFASFH PGLNPLERER LALAGPQLRP
     EMSYPDRLAA ERIHAERMAS LTSDPLARLQ MFNVTPHHHQ HSHIHSHLHL HQQDPLHQGS
     AGPVHPLVDP LTAGPHLARF PYPPGTLPNP LLGQPPHEHE MLRHPVFGTP YPRDLPGAIP
     PPMSAAHQLQ AMHAQSAELQ RLAMEQQWLH GHPHMHGGHL PSQEDYYSRL KKEGDKQL
//
